Sedivention

Sedivention
Developing a minimally invasive, one-time outpatient therapy for obesity treatment.
About
What does Sedivention do?
Sedivention is a Germany-based medtech startup focused on developing a minimally invasive, one-time outpatient therapy for the treatment of obesity. Their approach utilizes a targeted cryo procedure delivered via a specially designed balloon catheter to interrupt hunger-related signals in the vagus nerve. This aims to address the underlying physiological mechanisms of obesity and enable sustained appetite reduction without surgery, implants, or ongoing medication. The company has developed a fun…
What is Sedivention's revenue?
StartupHub estimates Sedivention's annual revenue at $1.6M (range $399K to $3.9M, 29% confidence), based on comparable companies in the sector.
What is Sedivention's valuation?
StartupHub estimates Sedivention's effective valuation at $39.2M (range $25.0M to $60.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Sedivention raised?
Sedivention has raised a total of $10M in funding. The most recent round on record is Seed.
Where is Sedivention headquartered?
Sedivention is headquartered in Berlin, Germany.
When was Sedivention founded?
Sedivention was founded in 2021.
What industry does Sedivention operate in?
Sedivention operates in Medical Devices, Biotechnology, HealthTech, Obesity Treatment, MedTech, Biotech.
No comments yet. Be the first to share your take.
